The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict. The existence of relationships does not necessarily imply bias or lessen the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers. The relevant commercial financial relationships or affiliations must have occured over the past 12 months.
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of completing the activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity. Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
Requirements for CE Credit
SIUE School of Pharmacy will transmit pharmacist activity completions to CPE Monitor. To view a list of all ACPE-accredited activities you have taken, log in to CPE Monitor at www.mycpemonitor. For information on the eligibility of this continuing education credit toward meeting your CME/CE requirements, please consult your professional association or state licensing board.
For questions regarding CME/CE activities, please email email@example.com
It is the responsibility of the participant to ensure that all course credits earned are present in their cpe monitor profile within the timeframe specified by ACPE.
- Apply the current ACCF/AHA guideline recommendations for pharmacotherapy in heart failure.
- Describe the mechanism of action of sacubitril-valsartan and identify common side effects.
- Describe the mechanism of action of ivabradine and identify common side effects.
- Propose a place in therapy for the novel heart failure agents.
Brief Bio : Sarah Cook is a PharmD candidate at the SIUE School of Pharmacy who is pursuing the education specialization. She plans to complete a general PGY1 residency after graduation and possibly continue on to pursue a PGY2 residency in critical care or geriatrics.
Disclosure : Sarah Cook has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Brief Bio : I am currently a PharmD Candidate attending SIUE School of pharmacy. I plan on pursuing a residency post-graduation.
Disclosure : Tate Hohulin has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.